These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34063379)

  • 1. A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
    Lai NS; Lu MC; Chang HH; Lo HC; Hsu CW; Huang KY; Tung CH; Hsu BB; Wu CH; Koo M
    J Clin Med; 2021 May; 10(10):. PubMed ID: 34063379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of SLE-DAS and SLEDAI-2K and classification of disease activity based on the SLE-DAS with reference to patient-reported outcomes.
    Onishi A; Tsuji H; Takase Y; Nakakubo Y; Iwasaki T; Kozuki T; Yoshida T; Shirakashi M; Onizawa H; Hiwa R; Kitagori K; Akizuki S; Nakashima R; Yoshifuji H; Tanaka M; Morinobu A
    Rheumatology (Oxford); 2023 Dec; 62(12):3909-3915. PubMed ID: 36943365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of disease activity with depression and anxiety in systemic lupus erythematosus: A comparison of SLEDAI-2K and SLE-DAS.
    Yang L; Gu B; Wang X; Ren Q; Shen M; Su D
    Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38305645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
    Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
    Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
    Abdelhady EI; Rabie M; Hassan RA
    Clin Rheumatol; 2021 Nov; 40(11):4553-4558. PubMed ID: 34142298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of hospital admissions with active systemic lupus erythematosus disease activity defined by two different disease activity indices: A cohort study.
    Wang CL; Koo M; Hsu CW; Lu MC
    Lupus; 2023 Jun; 32(7):864-872. PubMed ID: 37165549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of hospital admissions in patients with active systemic lupus erythematosus (SLE) classified according to two different SLE disease activity indices: a prospective cohort study.
    Lu MC; Hsu CW; Koo M; Lai NS
    Clin Exp Rheumatol; 2023 Jul; 41(7):1409-1416. PubMed ID: 36377575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
    Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
    Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual.
    Chitpet P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P; Leosuthamas P; Pakchotanon R
    Int J Rheum Dis; 2023 Dec; 26(12):2509-2516. PubMed ID: 37875327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS.
    Koo M; Lu MC
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of SLE-DAS in assessing disease activity in patients with systemic lupus erythematosus: a single-centre retrospective study.
    Ma J; Zhang L; Yan M; Liu Z; Xue L
    Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38862157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients.
    Ceccarelli F; Picciariello L; Natalucci F; Moretti V; Spinelli FR; Alessandri C; Conti F
    Clin Exp Rheumatol; 2024 Jul; 42(7):1491-1494. PubMed ID: 38819948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QRISK3-based analysis of cardiovascular risk factors in patients with long-term but well-controlled systemic lupus erythematosus.
    Wang SL; Li W; Li TF; Liang X; Yan YL; Liu SY
    Am J Transl Res; 2022; 14(5):3247-3260. PubMed ID: 35702101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with intimacy in female Taiwanese patients with systemic lupus erythematosus: a cross-sectional study.
    Hsu CW; Hsu BB; Koo M; Lu MC
    BMJ Open; 2022 Apr; 12(4):e055754. PubMed ID: 35428632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
    Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
    Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.
    Nantes SG; Strand V; Su J; Touma Z
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):125-133. PubMed ID: 28320078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO; Corrente JE; Saad-Magalhães C
    Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
    Ibañez D; Gladman D; Urowitz M
    J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential impact of disease activity and damage on health-related quality of life in patients with systemic lupus erythematosus.
    Riaz MM; Shen L; Lateef A; Cho J
    Lupus; 2022 Aug; 31(9):1121-1126. PubMed ID: 35676227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.